Fiona L Britten
Overview
Explore the profile of Fiona L Britten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Britten F, Lai C, Geddes D, Callaway L, Duncan E
Nutrients
. 2022 Apr;
14(7).
PMID: 35405936
(1) Background: Breastfeeding duration may be reduced in women with type 2 diabetes. Delayed secretory activation (SA) is associated with poorer breastfeeding outcomes; however, no prior studies have examined SA...
2.
Davidson S, de Jersey S, Britten F, Wolski P, Sekar R, Callaway L
Diabetes Res Clin Pract
. 2021 Feb;
173:108696.
PMID: 33592211
Aims: Some guidelines recommend altering glycemic targets in gestational diabetes mellitus (GDM) based on ultrasound measurements of fetal growth, but the impact on outcomes in clinical practice is unknown. The...
3.
Lee J, Britten F, Hartnett G
World J Nucl Med
. 2020 Dec;
19(3):317-318.
PMID: 33354197
No abstract available.
4.
Rudland V, Price S, Hughes R, Barrett H, Lagstrom J, Porter C, et al.
Aust N Z J Obstet Gynaecol
. 2020 Nov;
60(6):E18-E52.
PMID: 33200400
This is the full version of the Australasian Diabetes in Pregnancy Society (ADIPS) 2020 guideline for pre-existing diabetes and pregnancy. The guideline encompasses the management of women with pre-existing type...
5.
Duke M, Britten F, Pretorius C, McWhinney B, Ungerer J, Barrett H, et al.
J Endocr Soc
. 2019 May;
3(5):973-978.
PMID: 31041428
Context: Metyrapone is an inhibitor of endogenous adrenal corticosteroid synthesis, which has been proven to be a viable option in controlling maternal serum cortisol concentrations during pregnancy. The infant exposure...
6.
Rigg J, Gilbertson E, Barrett H, Britten F, Lust K
J Clin Endocrinol Metab
. 2018 Sep;
104(3):721-729.
PMID: 30247615
Context: Primary hyperparathyroidism (PHPT) in pregnancy has historically been associated with substantial maternofetal morbidity and mortality rates. The optimal treatment and timing of surgical intervention in pregnancy remain contested. Objective:...
7.
Britten F, Ulett K, Duncan E, Perry-Keene D
Med J Aust
. 2013 Oct;
199(8):556-8.
PMID: 24138383
No abstract available.